Effect of bovine lactoferrin on T lymphocyte cell phenotype and function and the response to vaccination in the neonatal piglet by Shunk, Jill
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Jill Marie Shunk 2012 
 
 
 
 
 
 
 
EFFECT OF BOVINE LACTOFERRIN ON T LYMPHOCYTE CELL PHENOTYPE AND 
FUNCTION AND THE RESPONSE TO VACCINATION IN THE NEONATAL PIGLET 
 
 
 
 
 
BY 
 
JILL MARIE SHUNK 
 
 
 
 
 
 
THESIS 
 
Submitted in partial fulfillment of the requirements  
for the degree of Master of Science in Nutritional Sciences  
in the Graduate College of the  
University of Illinois at Urbana-Champaign, 2012 
 
 
 
Urbana, Illinois 
 
 
 Master‟s Committee: 
 
 Professor Sharon M. Donovan, Director of Research 
Associate Professor Kelly S. Swanson 
Professor Jeffery A. Woods, Committee Chair
ii 
 
 
Abstract 
 
Deficiencies of the immune system, both innate and adaptive immunity, can weaken host 
defense and increase susceptibility to infection.  The immune system exists to guard the host 
against pathogenic infections, particularly at stressful time periods, such as birth and weaning. 
Proper nutrition and vaccination have positive effects for infant immune maturation. Lactoferrin 
(Lf), an iron binding glycoprotein found in breastmilk has been shown to have numerous 
physiological and immune properties that are nutritionally advantageous for infants.  
The goal of this thesis research was to discover how early nutrition influences immune 
maturation by investigating the addition of bovine Lf (bLf) to infant formula. The overall 
hypothesis of this research was that immune development is disparate between formula-fed and 
sow-reared piglets and that addition of bLf would enhance vaccination response and T-cell 
function in formula-fed piglets. To address this hypothesis, two specific aims were undertaken. N
 Specific Aim 1 investigated the effect of bLf supplemented to infant formula on the 
response to immunization against influenza virus and serum Ig profiles compared to piglets that 
were sow-reared or fed unsupplemented formula.  Newborn piglets were obtained at 4h of age 
and were fed either medicated sow milk replacer (FF; n=22) or sow milk replacer formula with 
1g/L bovine lactoferrin (bLf) (LF; n=22). A reference control group remained with the sow (SR; 
n=25).  Half of the piglets were further randomized into two groups to receive an IM injection of 
Fluzone™ on d7 and d14.  On d21 postpartum, piglets in each group were euthanized and blood 
and secondary lymphoid tissue samples were collected. Intestinal weight and length was 
collected immediately following euthanasia and serum was collected for analysis of Fluzone™-
IgG and total IgG and IgM concentrations. Formula intake between FF and LF piglets did not 
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differ. However, the body weight of the piglets was influenced by diet early in the study.  Sow-
reared piglets weighed more than both FF groups at day 3 and for the duration of the study 
(p<0.0001). LF piglet intake was approximately 0.38g/kg BW of Lf for the duration of the study.  
Also, at day 21 LF piglets weighed more than FF piglets (p<0.0001). When intestinal length was 
normalized by body weight (cm/kg), SR piglets had less normalized intestinal length in 
comparison to FF and LF. Similarly intestinal weights (g), which were normalized by body 
weight (g/kg) and intestinal length (g/cm), were significantly lower in SR piglets in comparison 
to FF and LF piglets (p<0.0001). A trend was observed in antibody response in dietary 
treatments, where SR piglets had greater Fluzone™-IgG versus the FF and LF groups 
(p=0.0953). However, LF had no impact on total IgG and IgM profiles.  
Specific Aim 2 examined the effect of bLf supplemented to infant formula on T-
lymphocyte phenotypes and cytokine secretion following ex vivo stimulation.  T-lymphocyte 
populations in peripheral blood mononuclear cells (PBMC), mesenteric lymph nodes (MLN) and 
spleen were stained with specific antibodies and identified by using flow cytometry.  T-cell and 
cytokine responses to ex vivo stimulation were assessed by ELISA. Both dietary (SR vs. LF vs. 
FF) and vaccination effects on immunological development were observed. Few differences in 
T-cell subpopulations were observed in PBMC, MLN and spleen. Yet, when vaccination was 
removed from the model, memory T-cells from PBMC were greater in FF piglets than LF 
piglets, but not different between SR piglets (p=0.0388). After ex vivo stimulation, numerous diet 
and vaccination effects were identified. First, changes in PBMC T-cells were observed after 
culturing. FF piglets had higher amounts of CD8+ T-cells than LF or SR (p<0.0001).  In 
contrast, SR piglets had higher T-helper cells (CD4+) than LF and FF piglets (p<0.0001). Also, 
LF piglets had decreased memory (CD4+CD8+) T-cells when compared to FF or SR piglets after 
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stimulation (p=0.0400). In the spleen, SR piglets had greater CD8+ T-cells than LF or FF piglets 
(p=0.0054). Yet, FF piglets had greater CD4+ T-cells than SR piglets, while LF was an 
intermediate (p=0.0006).  Again, diet differences were observed in the spleen, where SR piglets 
had higher amounts of CD4+CD8+ T-cells than LF or FF piglets (p=0.0004). In MLN, 
vaccinated piglets had greater CD8+ T-cells when stimulated than non-vaccinated piglets 
(p=0.0293). Yet in MLN supernatants, dietary differences were observed in FF piglets who 
secreted more IL-12 than LF or SR piglets from cells that were unstimulated or stimulated with  
PHA and PMA (p=0.0041). When vaccination was removed, spleen IL-12 cytokine production 
following Fluzone™ stimulation was affected by diet. LF piglets had higher IL-12 secretion than 
SR piglets, while FF was an intermediate (p=0.0394). Overall, vaccination and serum Ig profiles 
in the neonatal piglets were minimally affected by dietary supplementation of 1.0 g/L bLf.  
Dietary bLf was found to have little impact on T-cell phenotype or cell-mediated immune 
responses. More specifically, bLf decreased the percentage of memory T-cells in PBMC in 
comparison to SR and FF piglets. Dietary bLf was also found to have no negative impacts on 
development, dietary tolerance or immune characteristics analyzed. However, this data 
demonstrates differences that exist between SR piglets in comparison to FF and LF piglets and 
provide a framework for future dietary supplementation studies.   
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Chapter 1 
Literature Review 
 
Introduction to the Immune System 
 The immune system is divided into two categories: innate and adaptive. The innate 
immune system is comprised of cells and mechanisms that defend the host from infection in a 
non-specific manner, acting as the first line of defense.  It also functions to activate the adaptive 
immune system through a process known as antigen presentation through natural killer cells, T 
cells, and phagocyte cells such as macrophages, neutrophils and dendritic cells.  The adaptive 
immune system is composed of highly specialized cells and process to eliminate or prevent 
pathogenic growth.  Bridging innate and adaptive immunity, the major function of macrophages 
and T-cells is antigen recognition and clearance, thus coordinating the response of B-cells. The 
collaboration of the two systems is exceedingly effective at identifying pathogenic organisms 
from the host in order to function appropriately. 
 
Neonatal Immune Development 
The humoral immunity of the neonate is moderately underdeveloped, therefore, the infant 
must rely on maternal passive immunity prenatally and via colostrum and milk and proper 
nutrition (Calder et al., 2006). This immaturity of the immune system leaves infants vulnerable 
to foreign external stimuli and infection at an already stressful time of birth and weaning. In 
addition, the neonate‟s inability to respond to external cues from „self‟ does not the immune 
system to develop appropriate toleragenic responses when necessary. Food antigens are also a 
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common source of benign antigens that modulate immune maturation and preservation of 
tolerance as early as in the mother‟s womb (Warner et al., 1996).  
 Throughout pregnancy, immunological changes occur due to the polarization of a TH2 
bias between the mother and fetus (Reinhard et al., 1998). This response is necessary for the 
mother to not abort the infant during pregnancy; however, it yields a TH2 dominance in the fetus. 
After delivery, the TH2 bias must be down-regulated in order for the infant to not mount an 
allergen-specific IgE response to environmental or food-derived stimuli. Deficiency in the TH1 
T-cell associated cytokines also leaves the newborn susceptible to bacterial and viral infections 
due to the failure to actively attack foreign antigens (Reinhard et al., 1998). Furthermore, the 
switch to a more favorable TH1 environment in the neonate decreases its risk of developing 
future hypersensitivity by effectively responding to the environment.  
 Immunological factors that the infant is exposed to during delivery or obtains from 
breastmilk encourage maturation of the neonatal gut-associated and systemic immune systems. 
Nutrition, introduced through breastmilk, formula or solid foods, influences the microbial 
environment of the maturing intestine. Constant stimuli from food or environmental antigens 
affect maturation of the neonatal immune system and immune responses (Laubereau et al., 
2005).   
 
Neonatal Piglet Immune System 
The piglet is an excellent model for investigative studies of infant immune development. 
Unlike rodents, the piglet has a body size that facilitates surgical manipulations and long-term 
dietary treatment protocols (Guilloteau et al., 2010; Meurens et al., 2012).  In addition, the piglet 
has a more immature digestive system immediately after birth, yet similar nutrition and 
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gastrointestinal tract (GIT) development characteristics to human neonates (Sangild, 2003; 
Guilloteau et al., 2010). During the perinatal period, maturation of the GIT is highly influenced 
by the introduction of new foods. Dietary changes can be reflected in rapid intestinal growth, 
nutrient absorption, GIT immune function and bacterial colonization (Sangild, 2003).   
Piglets are also at risk for similar disease and pathogens to those that affect humans 
(Meurens et al., 2012). For example, swine influenza virus (SIV) is similar to human influenza 
virus. SIV is a highly contagious respiratory disease that disposes pigs to secondary infections 
that result in morbidity and mortality as high as 10% (Gao et al., 2012). More importantly, pigs 
with SIV are clinically analogous to influenza infected humans (Reeth et al., 2002).  
The immune system of swine is equivalent to that of humans as early as day 26 of 
gestation when innate immunity and inflammatory protein mediators are detectable (Calder et 
al., 2006; Šinkora et al., 2009). Piglets are also an excellent model for compromised immunity at 
birth, due to the low level of stimuli by external antigens during fetal development when leads to 
low levels of memory T cells and mature B cells at birth (Šinkora et al., 1998). This immaturity 
is consistent with underdeveloped lymph nodes and Peyers patches, and low levels of peripheral 
lymphocytes observed in newborn piglets (Šinkora et al., 2009).  
In contrast to human infants, piglets have no placental transfer of immunoglobulins from 
mother to fetus and are dependent upon uptake of colostral antibodies for passive immunity 
(Sangild 2003, Šinkora et al., 2009). Porcine colostrum contains very high levels of 
immunoglobulin-G (IgG). However, once the effective transfer of IgG has completed, gut 
closure occurs at 36-48h postpartum, which decreases the neonate‟s ability to absorb 
macromolecules. After the initial immunoglobulin (Ig) transfer, the composition of Ig resembles 
that of human colostrum and milk, predominating in immunoglobulin-A (IgA) (Bulter et al., 
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2009). Antibody transfer from limited amounts of colostrum has shown to be sufficient to 
provide protection against a pertussis challenge in newborn piglets (Elahi et al., 2006). However, 
mutating viruses such as influenza require oral or intramuscular vaccination for protection and 
these vaccinations have shown to be effective in piglets (Inskeep et al., 2010). 
 
Infant Response to Influenza Vaccination 
Infants are at increased risk for life-threatening complications caused by influenza, a 
respiratory tract infection. This contagious infection, which can progress to pneumonia, 
hypercytokinemia, acute lung injury, respiratory failure and death, kills ~36,000 Americans 
every year (Thompson et al., 2003; Fiore et al., 2008). Epidemics of influenza have greatly 
increased hospitalization rates of high-risk children under two-years-of-age at an average of 
1,181 per 100,000 persons annually. Patients considered high-risk for influenza infection, 
include patients with asthma, cardiovascular disease (CVD) or infants born prematurely. Even 
healthy infants have a 12-times greater likelihood of contracting influenza than older children 
ages 5-17 (Izurieta et al., 2000), increasing the urgency for influenza protection for vulnerable 
infants.  
The influenza virus consists of three different types: A, B and C.  Influenza A viruses can 
be separated into two subtypes based on two proteins on the virus‟s cell surface: hemagglutinin 
(H) and the neuraminidase (N). Although different subtypes for influenza type B do not exist, 
this type can be divided by strain. Influenza A (H1N1), A (H3N2) and influenza B viruses are 
included in each year‟s influenza vaccine because they cause seasonal epidemics of the disease 
every winter in the United States (CDC http://www.cdc.gov/flu/about/viruses/types.htm accessed 
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March 21, 2012). Respiratory syncytial virus (RSV) is the most common cause of lower 
respiratory tract infections in infants and young children. Although both viral infections occur 
seasonally, RSV dominates during late winter months, after the influenza season typically has 
come to an end (Izurieta et al., 2000).  
For people of all ages, influenza vaccines are the mainstay of efforts to prevent seasonal 
influenza.  Intramuscular injection has been confirmed to be 70-90% successful among children 
and healthy adults, although slightly lower among the elderly (Fiore et al., 2009).  One of the 
most commonly administered vaccines is Fluzone™,(Sanofi Pasteur, Swiftwater, PA) a trivalent 
inactivated vaccination that contains one influenza A (H3N2) virus, one seasonal influenza A 
(H1N1) virus, and one influenza B virus. This vaccine is administered by IM injection. Strains 
selected for the upcoming vaccine are thought to have the capacity to evade the immune system 
through mechanisms of mutation called antigenic drift, or variations of surface protein 
expression called antigenic shift (CDC 
http://www.cdc.gov/flu/professionals/vaccination/virusqa.htm accessed March 21, 2012).  
Vaccination is recommended for the general population and strongly encouraged for children 6 
months and older, pregnant mothers and the elderly (United States Department of Health and 
Human Services). Vaccination effectiveness varies depending on the ability of the person 
receiving the vaccination to produce a vaccine-induced immunity, yet limited research has been 
done in populations less than 6 months-of-age. Recently, a randomized, double-blind, placebo-
controlled trial conducted in the U.S. demonstrated that Fluzone™ administered to young infants 
(n=1,375) beginning at 6 to 12 weeks of age was safe and immunogenic (Englund et al., 2010).    
Two novel routes of vaccination against the flu have emerged in recent years: Fluzone 
Intradermal™ (Sanofi Pasteur) and FluMist™ (MedImmune, Gaithersburg, MD).  Fluzone 
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Intradermal™ is a trivalent inactivated vaccination that requires a less invasive procedure for 
administration by only puncturing the skin layer. It is currently only available for adults 18-64 
years of age. FluMist™ is a live trivalent vaccine offering defense against the seasonal flu, 
without the use of a needle, recommended for healthy people ages 2-49 years of age (CDC 
http://www.cdc.gov/flu/protect/vaccine/index.htm accessed March 22, 2012). Although Fluzone 
Intradermal™ and FluMist™ are capable of inducing protective immunity, recent studies have 
demonstrated that FluMist® was more protective than the other trivalent inactivated vaccines in 
children aged 6 months to 18 years of age (Ambrose et al., 2010).  
 
Nutritional Regulation of Immune Function 
Breastfeeding is essential to complete postnatal development by promoting and priming 
neonatal immunologic, gastrointestinal and central nervous systems.  Human milk contains its 
own immune system and a wide range of soluble and cellular factors, which likely facilitate the 
infant‟s immune development (Field, 2005). These factors include anti-microbial, anti-
inflammatory compounds such as immunoglobulins, cytokines, peptides, hormones, growth 
factors and a variety of important immune cells (Field, 2005). Recent studies have shown that 
breastfeeding compared to formula feeding induces differences in circulating T-cell phenotypes, 
including reduced CD4+:CD8+ T-cell ratio and an increase in natural killer (NK) cells (Hawkes 
et al., 1999).   
In the neonate, diet is a significant source of antigens to which the immune system must 
become tolerant. In addition, diet provides nutrients that shape intestinal flora, thereby also 
affecting antigen exposure, immune maturation and the subsequent responses.  The mucosal and 
epithelial surfaces form the first line of defense to the neonate, which emphasizes the importance 
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for proper intestinal development (Newburg and Walker, 2007). The critical mechanisms 
through early nutrition highly influence immune competence, the ability to develop toleragenic 
responses, and the development of immunological disorders (Calder et al., 2006).  
Epidemiological data provides strong evidence for a connection between undernutrition and life-
threatening infections in infants due to the functional immaturity of their innate immune system, 
and lack of adaptive immunity (Jones et al., 2010).   
Cell-mediated immunity to infectious pathogens has been shown to be inefficient during 
the neonatal period, further decreasing the neonate‟s immune defense (Fadel and Sarzotti, 2000). 
In newborns, successful TH1 responses are compromised due to decrease production of TH1 type 
cytokines produced by CD4+ T-cells and mononuclear phagocytes. In addition, neonatal 
macrophages have decreased response for IFN-γ production upon stimulation (Marodi, 2006). 
Specifically, a TH1 cytokine, IL-12, has been shown to selectively promote the differentiation of 
naïve CD4+ T-cells into effector TH1 CD4+ T-cells, thereby increasing IFN-γ. Upon LPS 
stimulation, a powerful pathogen-derived activator, neonatal mononuclear cells were less 
responsive than cells of an adult (Marodi, 2006).  
Two key factors that prevent disease and increase infant survival are breastfeeding and 
vaccination. In addition, a longer duration of breastfeeding elicits a rise of serological protection 
after vaccination. Exclusively breastfed infants for at least 90 days had an increased protection 
against Haemophilus influenza B vaccine (Hib) (Silfverdal et al., 1999). Since the rise of 
vaccines in the past 20 years, the correlation of the increased prevalence of allergic diseases and 
vaccinations has been of a focus of research and debate. Yet, the weight of evidence of the 
association suggests that vaccination alone cannot increase atopic disorders (Anderson et al., 
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2001). Also, breastfeeding has an analgesic effect on vaccination compared to formula-fed 
infants (Dilli et al., 2009).  
Many studies have shown that exclusive and even partial breastfeeding enhances 
immunity of the infant. Breastfeeding exclusively for 4 months, compared with feeding formula 
made with intact cow milk protein, has been shown to prevent or delay the incidence of atopic 
dermatitis, cow milk allergy and wheezing in infancy (Greer et al., 2008). In developing 
countries where infants are at risk for pneumonia, research has shown that exclusive or even 
partial breastfeeding decreases the incidences of pneumonia infections and subsequently 
hypoxemia (Chisti et al., 2011). 
 
Bioactive Components in Human Milk 
 Human colostrum contains many immune-competent cells and soluble proteins that are 
beneficial to the infant and aid in immune maturation. For example, colostrum stimulates the 
production of the cytokine IL-1, IL-3 and IL-6 from peripheral mononuclear cells (PBMC) 
(Bessler et al., 1996). More specifically, exosomes found in colostrum have been suggested to 
participate in directing immune responses in the infant. Upon isolation, functional analysis 
revealed exosomes inhibited non-lymphocyte production of IL-2 and IFN-γ from allogeneic and 
autologous PBMC (Admyre, 2007). Thus, providing optimal nutrition for infants unable to 
breastfed is critical for appropriate immunological maturation. 
Human milk is comprised of lipids, proteins and carbohydrates.  Some of these nutrients 
function as bioactive components that have physiological benefits. Some of these bioactive 
components found in breastmilk have recently been under investigation. Formula-fed piglets 
supplemented with nucleotides had higher poliovirus type 1 neutralizing antibody (PV-VN1) 
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responses after vaccination than their formula-fed controls (Schaller et al., 2004).  
Galactooligosaccharide (GOS) when supplemented to infant formula for 3 months has shown to 
significantly increase bifidobacteria, lactobacilli, stool acetic acid content and stool frequency 
compared to infants with no GOS, although statistically similar to breastfed infants (Ben et al., 
2008). 
  Lactoferrin (Lf), an iron binding glycoprotein in breastmilk has been shown to exert a 
variety of immune functions. Lf is produced by mammary tissue, grandular tissue on mucosal 
surfaces and can be found in secretory granules of polymorphonuclear leukocytes (Lönnerdal 
and Iyer, 1995). In nearly all organisms, iron serves as a cofactor for many important biological 
redox reactions, thus is an essential requirement for cell survival (Weingberg and Weingberg, 
1995). At mucosal surface where invading bacteria can inhabit, the iron can be bound by Lf, 
thereby decreasing growth of Gram-positive and Gram-negative bacteria (Moshynskyy et al, 
2003; Wakabayashi et al., 2009).   
 In the first 5 days of lactation, Lf is in highest concentration in colostrum and decreases 
by approximately 50%. Before 5 days of lactation, the concentration of Lf has been shown to be 
as high as 5.8g/L and 3.1g/L between 6 and 14 days. After the initial 14 days of lactation, 
lactoferrin further decreases to approximately 2g/L (Montagne et al., 1976). Yet, it is unclear if 
dietary, cultural or genetic factors influence the differences in Lf concentrations. Although the Lf 
concentration found in human milk is not depend on maternal iron status or iron supplementation 
(Lönnerdal and Iyer, 1995).  
Research has shown that Lf additionally has numerous physiological properties and 
immune-modulating effects. Oral administration of Lf increased IgG and IgA concentrations in 
the small intestine of mice and increased serum IgG in weaned piglets (Debbabi et al., 1998, Lee 
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et al., 2010). Lf has additionally been shown to have antioxidant activity from oral 
supplementation in human males. In addition to an increased T-cell activation after 14 days 
supplementation, the subjects had a statistically significant increase in hydrophilic antioxidant 
capacity (Mulder et al., 2008).  
 The presence of specific cellular receptors enables many biological activities of Lf. 
Lactoferrin receptors have been discovered in the small intestine, liver and bone in addition to 
monocytes, lymphocytes, platelets and fibroblasts (Suzuki et al., 2005). Recently, Lf has been 
illustrated as a glycoprotein with a double face, composed of an external surface robustly 
cationic and prone to interact with many negatively charged macromolecules. The internal 
portion is highly conserved among species and is dedicated to binding iron, which is sequestered 
in the two identical lobes. Lf‟s ability to bind and release iron alters its functional properties of 
iron scavenging, thus the structure and dynamics are altered by its present iron status (Baker and 
Baker, 2009). However, lactoferrin‟s receptor binding ability does not appear to be influenced by 
cellular iron status, unlike transferrin (Yamada et al., 1987). 
The innate immune response is the first line of defense against environmental insults, 
such as infectious pathogens, and it is mediated by pattern recognition receptors, especially Toll-
like receptors (TLR), present on specialized cells such as macrophages and dendritic cells (DCs).  
Lipopolysaccharide (LPS), a cell wall component of Gram-negative bacteria commonly induces 
septic like inflammation by binding of TLR-4. Lf has a LPS-binding domain, thereby down 
regulating the signal cascade that results in a release of pro-inflammatory mediators. In the 
presence of LPS, Lf injection increased survivability of mice by decreasing neutrophilia and 
subsequent TNF-α production (Yajima et al., 2005). Bovine lactoferrin (bLF) treated monocyte 
derived dendritic cells (MD-DC) failed to undergo activation in response to TLR stimulation. 
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This in vitro research demonstrates that bLF acts as a potent anti-inflammatory agent on 
monocytes by creating a tolerogenic-like program during differentiation into DCs (Puddu et al., 
2011). Lf has additionally been shown to have antimicrobial effects when orally administered. 
Weaned piglets fed Lf transgenic rice for 28 days exhibited lower aerobic and anaerobic bacteria, 
as well as coliform counts in cecal contents than the control group (Lee et al., 2010).  
 Because Lf is resistant to digestion and excreted in high levels in the stool of breast-fed 
infants, its effect on viral replication has been widely researched. It has been established that Lf 
is a potent inhibitor of the growth of several naked viruses such as rotavirus, adenovirus and 
enterovirus (Seganti et al., 2004). In vitro experimentation using a human enterocyte-like cell 
line showed that Lf is capable of reducing rotavirus attachment to cell receptors, therefore 
preventing the virus‟s ability to replicate (Superti et al., 1997). Recently, Lf has been studied as 
an additive to oral rehydration solutions (ORS) for enhancing treatment of virus induced diarrhea 
and subsequent hospitalizations was studied. Peruvian children receiving Lf-lysozyme 
supplemented ORS (1g/L lactoferrin and 0.2g/L lysozyme) had a significantly reduced duration 
of diarrhea (Zavaleta et al., 2007).  
Lf additionally has been shown to stimulate proliferation of immune cells. Weaned 
piglets fed Lf (50mg/kg BW) isolated from transgenic rice had a higher number of lymphocytes, 
an increased percentage of T-cells and a decreased number in B lymphocytes (Lee et al., 2010). 
In addition, IP injection of Lf in C57BL/6NCr mice induced substantial infiltration of neutrophils 
4 hours after injection and macrophages after 24 hours (de la Rosa et al., 2008). 
Recent studies using porcine lactoferrin (pLf) and bLf have suggested the potential for Lf 
to enhance vaccination response. In chickens, pLf (2.0% w/w) was used as a feedstuff additive to 
examine its impact on peripheral lymphocyte proliferation and serum antibody titers in chickens 
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vaccinated against the infectious bursal disease (IBD). The addition of pLf also led to significant 
increases in total serum IgA and IgG and in IBD-specific antibody titers. Moreover, the 
expression of IFN-γ and IL-12 from T-cells was increased, suggesting that pLf enhanced cell 
mediated immunity and augmented the ability of the vaccination to strengthen subsequent anti-
viral responses (Hung et al., 2010).   
The immune modulatory activities of Lf include its ability to promote antigen specific 
cell-mediated immunity in C57BL/6 and BALB/c mice immunized with Mycobacterium bovis 
bacillus Calmette Guerin (BCG) with recombinant human Lf. BCG/Lf-immunized mice had a 
significant decrease in the development in pulmonary pathologies compared to immunized 
groups following Mycobacterium tuberculosis infection (MTB) (Hwang et al., 2009a). In 
addition, the splenocytes of these animals had significantly more CD4+ T-cells producing 
intracellular interferon-gamma (IFN-γ) in a group in which Lf was used as an adjuvant (<0.2 
E.U./mg).  This is important because in vivo studies have shown that type I interferons (IFN) are 
an influential vaccine adjuvant for increasing immune protection against influenza virus. IFN 
cytokines promote differentiation, survival and function of immune cells and enhance antibody 
response. The cellular immune response is crucial in order to clear the virus infection or respond 
to a vaccine, including innate NK cells and adaptive T-cells. In children (6 months to 4 years of 
age) the production of IFN-γ by T-cells and NK cells has been determined before and after 
vaccination. Peripheral blood mononuclear cells (PBMCs) from vaccinated animals stimulated in 
vitro with live influenza A virus had significantly higher IFN-γ producing cells from CD4+ T-
cells and NK cells, suggesting a relationship between innate and adaptive immunity for viral 
infections and vaccination (Proiette et al., 2002). 
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In addition, under ex vivo stimulation of LPS, Lf increased the ratio of IL-12:IL-10 
cytokines from murine leukocytes. In vitro experimentation with the addition of bLf to BCG 
infected macrophages also increased the IL-12:IL-10 ratio (Hwang et al., 2006). Thus, Lf has 
been shown to promote TH1 mediated response.   
 It is known that bioactive compounds found in breastmilk help direct and educate the 
infant‟s immune system and maturation (Dorea, 2009). Research has proven numerous 
immunological benefits of Lf, however experiments conducted with antigen-specific immunity 
only investigate Lf either mixed with the vaccine, injected or added in vitro.  Numerous sources 
and dosages of Lf has been researched (Table 1.1), but the ability of bLf to stimulate the 
influenza vaccination response in vivo has not been analyzed. In addition, T cell phenotype 
differentiation has not been assessed upon activation ex vivo.   
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 Table 1.1.  Concentrations and sources of lactoferrin used as a food additive or adjuvant in research. 
  Lf Source and 
Dose 
How Administered Effect Reference 
pLf: 2.0% w/w Oral supplementation 
in chickens 
Increased serum IgA and 
IgG; 
Increased IBD-antibody 
specific concentration 
Hung et al. 2010 
bLf: 0.2 E.U./mg Used as an adjuvant. Increased percentage of IFN-
γ producing CD4+ T-cells 
Hwang et al., 2009a 
Recombinant Lf: 
50mg/kg BW 
Oral supplementation 
to weaned piglets 
Increased concentrations of 
lymphocytes and T-cells 
Decreased concentration of 
B-cells 
Lee et al., 2010 
Recombinant Lf: 
1g/L  
Additive in ORS to 
children 
Reduced duration of diarrhea Zavaleta et al., 2007 
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Chapter 2 
Research Objectives, Specific Aims, and Hypothesis 
Influenza infections are a major cause of morbidity and mortality in infants each year.  
Proper nutrition and vaccination are two key factors that increase protection from infection and 
improve infant survival. Maternal milk provides the best nutrition by enhancing immunity of the 
infant. For examples, infants who are exclusively breastfed for at least 90 days had a better 
response to vaccination (Silfverdal et al., 1999). Although there are many evident immunological 
benefits of breast feeding, only 3 of 4 mothers initiate breastfeeding, and of that only one-third of 
infants are exclusively breast fed up to 3 months (CDC, 2011). Thus, identifying bioactive 
components for that could support proper immune development for formula-fed infants is under 
constant investigation.   
The overall goal of this thesis research was to discover how early nutrition influences 
immune maturation by investigating the addition to bLf to infant formula. The overall hypothesis 
of this research was that immune development is disparate between formula-fed and sow-reared 
piglets and that addition of bLf would enhance vaccination response and T-cell function in 
formula-fed piglets. To address this hypothesis, two specific aims were undertaken.  
Specific Aim 1 investigated the effect of bLf supplemented to infant formula on the 
response to immunization against influenza virus and serum Ig profiles compared to piglets that 
were sow-reared (SR) or fed unsupplemented formula (FF). The working hypothesis was that 
supplementation of bLf would promote a greater immunoglobulin response to immunization, and 
higher concentrations of total serum IgG and IgM than FF piglets and would be more 
comparable to SR piglets. Chapter 3 compared Fluzone™-specific IgG and total IgG and IgM 
16 
 
concentrations in the serum of vaccinated and non-vaccinated piglets in the three dietary 
treatment groups.  
Specific Aim 2 examined the effect of bLf supplemented to infant formula on T-cell 
populations, T-cell and cytokine responses to ex vivo stimulation compared to FF and SR piglets. 
The working hypothesis of this specific aim was that supplementation of formula with bLf 
would elicit a more robust immunological development of piglets compared to those fed formuia 
alone, which would be shown through greater percentages of memory T-cell populations. 
Furthermore, dietary bLf would lead to higher expression of TH1 cytokines upon stimulation.  It 
was also hypothesized that T-cell phenotype, cell-mediated immune response and cytokine 
production would be affected by vaccination.   
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Chapter 3 
Impact of Bovine Lactoferrin on Serum Immunoglobulins and Response to Influenza 
Vaccination in the Neonatal Piglet 
 
Abstract 
 Neonatal immune development is vital in order to protect the infant from pathogens in the 
external environment, exposure to which could lead to an unfavorable and potentially life-
threatening response. Lactoferrin, an iron-bind protein has been shown to have numerous 
immune modulating effects.  We hypothesized that bovine lactoferrin-fed piglets would develop 
immunoglobulin profiles parallel to that of sow-reared piglets, but different from formula-fed 
piglets. Newborn piglets fed colostrum for 4h were randomized into three groups by litter and 
body weight. Dietary groups consisted of a non-medicated sow milk replacer (FF; n=22), the 
milk replacer supplemented with 1g/L bovine lactoferrin (LF; n=22) or the piglets remained with 
the sow (SR; n=25) throughout the duration of the study. On d7 and d14, half the piglets in each 
group were further randomized to receive Fluzone™ vaccination at the pediatric dose (0.25mL) 
by IM injection. Blood samples were collected on d7 and d14 by jugular puncture.  On d21 
postpartum, the piglets were euthanized and blood and tissue samples were collected. Total 
intestinal length and weight was taken immediately and measured from the pyloric sphincter to 
the ileocecal valve. In serum, total IgG and IgM concentrations and Fluzone™-specific IgG 
levels were analyzed by enzyme linked immunoabsorbent assays (ELISA). Formula intake 
between FF and LF piglets did not differ. However, the body weight of the piglets was 
influenced by diet early in the study. Sow-reared piglets weighed more than both FF groups at 
day 3 and for the entire duration of the study. Also, at day 21 LF piglets weighed more than FF 
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piglets. When absolute intestinal length (cm) was normalized by body weight (cm/kg), SR 
piglets had shorter intestinal length compared to FF and LF. However, FF and LF piglets showed 
no difference in intestinal length. Similarly intestinal weights (g), which were normalized by 
body weight (g/kg) and intestinal length (g/cm), were significantly lower in SR piglets in 
comparison to FF and LF piglets. In the LF piglets, daily bLf intake increased from 0.46g/d at d1 
to 2.4g/d at d21. Normalized by BW, the average bLf intake was 0.38g/kg BW throughout the 
study. Identified by ELISA, vaccinated piglets had a higher Fluzone™-specific IgG levels at d21 
than non-vaccinated and tended to have higher Fluzone™-IgG than FF and LF groups.  Total 
IgG concentration was greater in all dietary treatments at d21 in comparison to d7 and d14. 
However, no vaccination or dietary effects were found. Total IgM concentration on d7 for all 
dietary treatments was greater than d14 and d21. On d14, SR piglets had higher amounts of IgM 
than LF piglets, both were not different from the FF piglets.  Diet differences were also seen on 
d21 as SR piglets had higher serum IgM than LF and FF piglets. The findings of this study have 
established the impact of formula supplemented with bovine Lf and its implications on IgG, IgM 
and Fluzone™-specific IgG. Furthermore, these data demonstrated that differences exists 
between SR piglets in comparison to FF piglets and provide a framework for future dietary 
supplementation studies to increase the infant‟s ability to develop an antigen-specific antibody 
response for protection.  
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Introduction 
After birth, humoral immunity of the neonate is moderately underdeveloped making the 
infant rely primarily on maternal immunity and proper nutrition. An ongoing challenge for the 
medical field today is to provide proper nutrition for infants who are unable to breastfeed. 
Therefore, research is necessary to identify compounds found in breastmilk but absent in 
formula, to ensure optimal development of the neonate. Throughout this period of rapid 
development, the infant is dependent on their immature immune system for protection to defend 
themselves against foreign external stimuli. Nutrition is also a common source of these benign 
antigens that modulate immune maturation and preservation of tolerance throughout infancy 
(Calder et al., 2006). Thus, we investigated the effects of a lactoferrin (Lf), a bioactive 
breastmilk protein, on the innate immune system in the neonatal piglet as a model for the human 
infant.  
Lf is an iron-binding glycoprotein that has been shown to have various physiological 
properties that affect immune system development and function. Lf has been shown to have anti-
bacterial and anti-viral properties. On the mucosal surface where invading bacteria can inhabit, 
Lf has the ability to bind iron thus minimizing cell growth of Gram-positive and Gram-negative 
bacteria (Moshynskyy et al., 2003; Wakabayashi et al., 2009). In addition, Lf demonstrated its 
ability to reduce rotavirus attachment to cell receptors in vitro, therefore preventing the virus‟s 
ability to replicate (Superti et al., 1997).   
In addition to the immunomodulatory effects of Lf, oral administration of this 
glycoprotein has been shown to enhance total and antibody-specific immunoglobulin maturation. 
Oral supplementation of Lf increased IgG and IgA concentrations from small intestinal mucosa 
in mice and higher IgG in serum of weaned piglets (Debbabi et al., 1998; Lee et al., 2010).  
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Studies using porcine (pLf) and bovine (bLf) lactoferrin have suggested the potential for Lf to 
enhance vaccination response. The addition of pLf led to significant increases in total serum IgA 
and IgG and in infectious bural disease (IBD) virus-specific antibody titers (Hung et al., 2010).   
Despite the positive findings of Lf on antibody enhancement, minimal research has been 
done to investigate the impact of orally supplemented Lf on antibody-specific immunoglobulin 
development and T-cell responses in a neonatal model. Therefore, the presented research 
explores the effects of dietary Lf on the immunological development during vaccination in 
piglets less than three weeks of age. Outcomes included body weight, Lf intake, intestinal weight 
and length, and circulating concentrations of antibody specific and total immunoglobulins.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21 
 
Materials and Methods 
Chemicals 
 All chemicals were purchased from Sigma-Aldrich (St. Louis, MO), unless otherwise 
specified. 
 
Bovine Lactoferrin 
bLf was obtained from FrieslandCampina, Netherlands. The protein content of the bLf 
was 98% and iron content is 120mg/kg. Assuming all iron was bound, the iron saturation of Lf 
was 11.9%.  
 
Dietary Treatment and Animal Protocol 
 All animal procedures were approved by the Institutional Animal Care and Use 
Committee of the University of Illinois. Pregnant sows were purchased from Midwest Research 
Swine (Gibbon, MN) and transported to the Edward R. Madigan Laboratory (ERML) at the 
University of Illinois one month prior to farrowing. Upon arrival, sows were vaccinated with 
LitterGuard LT-C (Pfizer Animal Health, Exton PA), Respisure (Pfizer Animal Health), and 
BPE (Intervet Inc., Millsboro, De), followed by a booster vaccination two weeks prior to 
farrowing and were placed on gestation diet. The sows were allowed to farrow naturally unless 
induction with Lutalyse (Pfizer, 2mL intramuscular (IM) injection [10mg]; Pfizer Animal 
Health, Fort Dodge, IA) was necessary. Piglets were allowed to suckle for 4h to receive 
colostrum before being randomized to receive a non-medicated sow milk replacer formula (FF; 
n=22) (Advance Baby Pig Liquiwean, Milk Specialities Global Animal Nutrition, Dundee, IL) or 
formula supplemented with 1g/L bLf (LF; n=22). Piglets were individually housed in 
environmentally controlled rooms (25°C) in cages that maintained three piglets separated by 
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Plexiglas partitions. Piglets were weighed each morning and formula was provided by a pump in 
22 equal feedings at a total volume of 360 ml/kg BW/day. The remaining piglets (n=25) were 
sow-reared (SR) and were allowed to nurse ad libitum and were not given creep feed, although 
by d21 piglets were observed consuming minimal feed from the sow‟s bin.  
 
Vaccination 
 On d7, half of the piglets in each dietary treatment were randomized equally into two 
groups, vaccination (V) and non-vaccinated (NV) [FF-NV; n= 11, FF-V; n=11, LF-NV; n=10, 
LF-V; n=11, SR-NV; n=13, SR-V; n=11]. On d7 the FF-V, LF-V and SR-V groups were 
vaccinated with the pediatric dose (0.25mL) of Fluzone™ (Sanofi Pasteur, Swiftwater, PA) by 
IM injection and were given a booster on d14. Blood samples were obtained by jugular puncture 
at d7 and d14, or following euthanasia at d21.    
 
Sample Collection 
 On d21 postpartum, piglets were sedated with an IM injection of Telazol (3.5 mg/kg SW 
each Tiletamine HCl and Zolazepam HCl, Pfizer Animal Health, Fort Dodge, IA). After 
sedation, blood was collected by cardiac puncture into non-coated vacuum tubes (BD 
Biosciences, Franklin Lakes, NJ) for serum isolation. Piglets were then euthanized by an 
intravenous injection of sodium pentobarbital (72 mg/kg BW Fatal Plus, Vortech 
Pharmaceuticals, Dearborn, MI). After euthanasia, the small intestine was removed from the 
pyloric sphincter and to the ileocecal valve. The small intestine was measured and cut at 10% 
and 85% from the proximal end to give 3 segments corresponding to the duodenum, jejunum and 
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ileum, respectively. Each section was weighed and snap frozen in liquid nitrogen. Spleen and 
mesenteric lymph nodes (MLN) were then collected for isolation of mononuclear cells.  
 
Assessment of Serum Immunoglobulin Levels 
 Serum IgG and IgM concentrations were quantified using a porcine specific ELISA 
Quantification Set (Bethyl Laboratories, Montgomery, TX). Briefly, 96-well, flat-bottomed 
plates (Nune, Rochester, NY) were coated with 100μl of coating antibody (μg concentration used 
was advised by the manufacturer diluted in 0.05M carbonate-bicarbonate buffer, pH 9.6) then 
incubated at 4°C overnight. Once the coating antibody was decanted, the plate was washed three 
times with PBS/0.05% Tween20. The plates were blocked with 300μl of 3% BSA/PBS for 1 h at 
room temperature (RT). The plates were washed as before and serum samples were serially 
added to the wells in duplicate (100μl), diluted in 0.05% gelatin/PBS and incubated for 1 h at 
RT. The quantification set included samples for standard curves, which were used as directed. 
Plates were washed as before, and 100μl of HRP-conjugated detection antibody (concentration 
recommended by the manufacturer) in 0.05% gelatin/PBS was added to each well. Plates were 
removed from light and incubated for 1 h at RT.  Plates were then washed three times with PBS-
Tween 20. Next, 100μl TMB reagent solution (OptEIA, BD Biosciences, San Diego, CA) was 
added to each well and allowed to develop protected from light at RT for the recommended time 
by the manufacturer. The reaction was stopped with 100μl 2N H2SO4 per well and the 
absorbance was read at 450nm with 570nm correction using a microplate reader (SpectraMax 
M2
e
, Molecular Devices, Sunnyvale, CA). Total immunoglobulin values were determined based 
on a standard curve that was run on each plate. 
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Assessment of Antibody Response 
 An enzyme-linked immunosorbent assay (ELISA) kit was developed in the Donovan 
laboratory to detect porcine Fluzone™-specific IgG. Flat bottomed plates (Nunc, Rochester, NY) 
were coated with dialyzed 50μl dialyzed Fluzone™ (1:80 dilution) in coating buffer [0.5M 
Carb/Bicarb Buffer, pH 9.6] and incubated overnight at 4°C. After the incubation, 200μl of 
PBS/10% FBS was added to each well to block non-specific binding for 1 h at RT. Following 
incubation, the plates were washed three times with PBS/0.05%Tween 20 and 50μl of serially 
diluted serum was added to each well and incubated for 1 h at 37°C. The plates were then 
washed three times with PBS/Tween and 50μl of goat anti-pig IgG conjugated HRP (Bethyl 
Laboratories) was added to each well at a 1:400 dilution in PBS/10% FBS then incubated for 1 h 
at 37°C. After washing as before, 50μl of TMB (BD Biosciences, San Diego, CA) was added and 
allowed to develop at RT. After 20 min, the reaction was stopped by 50μl 1M sulfuric acid.  The 
plate was then analyzed on a microplate spectrophotometer (SpectraMax M2
e
, Molecular 
Devices, Sunnyvale, CA) at 450nm and 570nm for correction. Positive stock serum from an SIV 
infected sow was run on each plate in dilutions ranging from 1:100-1:50,000 and used as the 
standard curve. Fluzone™-specific IgG was expressed as optical density (O.D.) from a 1:100 
dilution.   
 
Statistical Analysis 
 Analyses were completed using PROC GLM (general linear model) procedure within 
SAS (Version 9.2, SAS Institute, Cary, NC). The initial model tested was replicate, litter, diet 
and vaccination; however if the replicate was not significant, it was removed from the model.  
Diet included three groups: FF, LF and SR. The final model was vaccination, diet, and 
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vaccination*diet interaction. Diet included three groups: FF, LF and SR. If lactoferrin was not 
significant, LF and FF piglets were combined. If the vaccination was not significant, vaccinated 
and non-vaccinated were combined. Daily weight gain was analyzed by Chi-squared test using 
the PROC MIXED procedure within SAS. Statistical significance was defined as p<0.05, with 
trends reported as p<0.10. All data are expressed as means ± SD.  
 
Results 
Formula Intake and Body Weight 
 Formula intake (Figure 3.1) and body weight (Figure 3.2) were measured daily to 
determine whether bLf affected piglet growth. Formula intake was similar among the two diets 
and averaged 1076 ± 189 and 1088 ± 178 mL/day for the FF and LF, respectively, over the 21-
day study period. Vaccination showed no effect on intake or body weight gain. Although average 
body weight in each diet group was not different at d0, from d3 to d21 body weight of SR was 
greater (p<0.05) than those of FF and LF. This can also be observed from the first two weeks, 
where average weight gain was significantly greater (p<0.001) in SR than FF or LF piglets. Yet, 
on day 21 body weight of LF was greater (p<0.05) than FF on d21. Therefore, during week 3, 
average weekly weight gain of SR and LF did not differ, but was significantly greater (p<0.01) 
than those of FF. At d21, weights averaged 5.46±1.14kg for FF-NV, 5.51±1.31kg for FF-V, 
6.09±0.91kg for LF-NV, 5.85±0.78kg for LF-V, 7.68±1.3 for SR-NV, and 7.33±1.37kg for SR-V 
piglets.    
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Lactoferrin Intake 
 Lf intake was not different between vaccinated and non-vaccinated groups (p=0.5941) 
(Figure 3.3). Over the 21 day feeding period, bLf intake increased from ~0.5 to 2g/d. Daily 
average bLf intake per kg BW was approximately 0.38g/kg BW for the duration of the study.  
 
Intestinal Weight and Length 
 Total intestinal length (Figure 3.4a) and weight (Figure 3.4b) were not significant 
between dietary and vaccination groups (p=0.8832 and p=0.4456), respectively. However, 
absolute intestinal length, normalized to body weight (cm/kg) was lower (p<0.05) decreased in 
SR piglets compared to FF and LF (Figure 3.5a). However, FF and LF piglets showed no 
difference in intestinal length. Intestinal lengths normalized by body weight at d21 by dietary 
treatments were: 148.83±21.73 cm/kg for FF, 141.219±17.8 cm/kg for LF, and 114.08±17 cm/kg 
for SR piglets. Similarly intestinal weights normalized by body weight (g/kg) and intestinal 
length (g/cm), were significantly lower in SR piglets in comparison to FF and LF piglets (Figure 
3.5b). 
 
Assessment of Antibody Response 
 A Fluzone™-specific IgG ELISA was developed to establish whether bLf increased 
antibody titers in response to the vaccination. Only samples from November and December 2011 
replicates were used for this analysis. Serum concentrations were evaluated at d7, d14 and d21 to 
analyze antibody production over time. Vaccinated piglets had a significantly higher IgG titers at 
d21 than non-vaccinated (p<0.0001). There were differences in Fluzone™-IgG versus SR piglets 
and the FF and LF groups, but not statistically different (p=0.0953) (Figure 3.6). 
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Total Serum Immunoglobulin Levels  
 Total IgG and IgM was assessed by ELISA kit to investigate dietary and vaccination 
treatments on immunoglobulin concentrations. For total IgG concentration, d21 was statistically 
different from d7 and d14 (p<0.0001) (Figure 3.7). When days were analyzed separately, d7 had 
a trend (Model: p=0.0560) in vaccination (p=0.0562) for V piglets to have higher IgG. Also, a 
trend was seen for dietary treatments (p=0.0579) for FF piglets to have higher IgG, than SR and 
LF fed piglets.  No statistical differences were observed on d14 or d21 (p=0.3395 and (p=0.3122 
respectively). When all days were run using PROC MIXED, an interaction was seen between 
diet and day (p=0.0460) for total IgG. FF-d7 and SR-d14 are statiscally different than all diet 
groups at d21. 
 Total IgM concentration was also assessed by ELISA kit (Figure 3.8). Day 7 was found 
to be statistically different from d14 and d21 (p<0.0001).  Diet significance was found when 
days were analyzed separately on d14 (Model: p=0.0396) and d21 (Model: p=0.0151) but not on 
day d7 (Model: p=0.7160). On d14, SR piglets significantly greater amounts of IgM than LF 
piglets, both not different from the FF piglets (p=0.0085).  On d21, diet differences were again 
seen. SR piglets had statistically higher quantities of serum IgM than LF and FF (p=0.0016).  
When all days were analyzed together using PROC MIXED, a vaccination effect was not seen, 
but diet differences were. SR piglets had greater IgM than LF piglets, but were not different from 
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FF piglets (p=0.0294) 
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Figure 3.1. Average Daily Formula Intake (mL/d) of Formula-Fed Piglets. Neither bLF 
nor vaccination affected formula intake. Data are expressed as means±SD. 
Model: p<0.2031 
Diet: p<0.6540 
Vaccination: p=0.0954 
Day: p<0.0001 
Diet*Interaction: p=0.6972 
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Figure 3.2. Average Daily Body Weights (kg) of Piglets Between Birth and d21 
Postpartum.   At d3, SR were significantly heavier than  FF and LF fed groups. At d21, LF 
piglet weight is significantly greater than that of FF piglets. Data are expressed as means±SD. 
 
Model: p<0.0001 
Diet: p<0.0001 
Vaccination: p=0.4623 
Day: p<0.0001 
Diet*Interaction: p=0.6972 
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Figure 3.3.  Daily bLf  Intake (g/d) Between d1 and d21. Lactoferrin intake was not 
affected by vaccination (p=0.5941). Data are expressed as means±SD. 
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Figure 3.4. Total Intestinal Length (top panel) and Weight (bottom panel) on d21. 
Neither weight nor length was affected by diet or vaccination (p=0.8832 and p=0.4456 
respectively).  Data are expressed as means±SD. 
Model: p=0.4456 
Vaccination: p=0.1956 
Diet: p=0.5339 
Vaccination*Diet: p= 0.5730  
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Figure 3.5. Average Intestinal Length (top panel) and Weight (bottom panel) 
Normalized by Body Weight on d21. Intestinal length (cm/kg) was shorter in SR piglets 
than FF or LF groups (p<0.0001). Intestinal weight of SR piglets was lower than FF and 
LF groups (p<0.0001). Vaccination had no effect on normalized intestinal weight or 
length. Data are expressed as means±SD. Different letter superscripts indicate significant 
differences.  
Model: p<0.0001 
Vaccination: p=0.1323 
Diet: p<0.0001 
Vaccination*Diet: p= 0.9342 
B 
Model: p<0.0001 
Vaccination: p=5600 
Diet: p<0.0001 
Vaccination*Diet: p= 0.7697 
 
A 
B 
 
A 
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Figure 3.6. Serum Fluzone™ IgG Concentration on d21.  Fluzone™ IgG was 
undetectable in non-vaccinated piglets (data not shown).  SR piglets had a trend towards 
higher Fluzone™ IgG than FF and LF piglets, but values were not statistically different. 
Data are expressed as means±SD. 
Model: p<0.0001 
Vaccination: p<0.0001 
Diet: p=0.0953 
Vaccination*Diet: p=0.0953  
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Figure 3.7. Total IgG Concentration in Serum on d7, 14 and 21. Values on day 21 
were statistically different from d7 and d14 (p<0.0001). An interaction was seen between 
diet and day. Using LS Means, FF-d7 and SR-d14 were denoted as A. LF-d7, LF-d14, FF-
d14 and SR d7 are AB, and all diet groups at d21 are denoted as C. Data are expressed as 
means±SD. 
Model: p<0.0001 
Vaccination: p=0.6615 
Diet: p=0.0604 
Day: p<0.0001 
Vaccination*Day: p=0.1260 
Diet*Day: p=0.0460 
Vaccination*Diet: p=0.4673 
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Figure 3.8. Serum IgM Concentration on d7, 14 and 21. Concentrations on day 7 were 
statistically higher than d14 and d21 (p<0.0001).  SR piglets had greater IgM than LF 
piglets, but not different than FF piglets (p=0.0294). There was no effect of vaccination. 
Data are expressed as means±SD. 
 
Model: p<0.0001 
Vaccination: p=0.8703 
Diet: p=0.0294 
Day: p<0.0001 
Vaccination*Day: p=0.8915 
Diet*Day: p=0.8014 
Vaccination*Diet: p=0.6392 
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Chapter 4 
Impact of Bovine Lactoferrin and Vaccination on T Lymphocyte Phenotype and Response 
to Mitogen Stimulation Ex Vivo in the Neonatal Piglet  
 
Abstract 
Neonates are born in a TH2 bias environment and the early postnatal switch to a more 
favorable TH1 T-cell phenotype decreases the risk of developing future hypersensitivity by 
effectively responding to the environment. Immunological factors from delivery and breastmilk, 
such foreign antigens, are key aspects that encourage maturation of the neonatal gut-associated 
and systemic immune systems. Lactoferrin (Lf), a glycoprotein found in human milk has been 
shown to affect T-cell proliferation and activation. Peripheral blood mononuclear cells (PBMCs), 
mesentery lymph nodes (MLN) and spleen were collected for immune cell isolation from the 
study described in Chapter 3. T-lymphocyte subpopulations were identified using flow 
cytometry. Immune cells were also placed into culture and stimulated with mitogens and 
Fluzone™ ex vivo for 48hr and 72hr. T-lymphocyte subpopulations were again determined by 
flow cytometry and supernatants were collected for cytokine analyses by ELISA. Both dietary 
(SR vs. LF vs. FF) and vaccination effects on immunological development were observed. No 
effect of vaccination on T-cell subpopulations was observed in PBMC, MLN or spleen but 
memory T-cells from PBMC were greater in FF piglets than LF piglets, but not different between 
SR piglets. After ex vivo stimulation, both diet and vaccination effects were observed. 
Stimulation PMA was consistently different from other stimulants (unstimulated, Fluzone™, 
PHA and LPS). In PBMC, FF piglets had higher amounts of CD8+ T-cells than LF or SR after 
48 hr in culture. In contrast, SR piglets had higher T-helper (CD4+) cells than LF and FF piglets 
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after stimulation. Also, LF piglets had lower memory (CD4+CD8+) T-cells when compared to 
FF or SR piglets after stimulation. Although vaccination had little effect on spleen T-cell 
subpopulations after stimulation, diet differences were seen. In the spleen, SR piglets had greater 
CD8+ T-cells than LF or FF piglets. Yet, FF piglets had greater CD4+ T-cells than SR piglets, 
but LF did not differ between the two groups. Again, diet differences were observed for 
CD4+CD8+ T-cells in the spleen where SR piglets had higher amounts than LF or FF piglets.  In 
MLN, no dietary differences were observed, but vaccination had an impact on CD8+ T-cells 
after stimulation. Vaccinated piglets had greater CD8+ T-cells when stimulated than non-
vaccinated piglets. However, no differences were seen in MLN T-helper cells or memory T-cells 
from stimulation. Cytokine production was analyzed by ELISA from ex vivo stimulated MLN 
and spleen cell supernatants. Vaccination and dietary differences were not detected, but 
cytokines IL-10 and IL-12 differences were seen between stimulation in the spleen supernatants. 
When vaccination was removed, spleen IL-12 cytokine production from Fluzone™ stimulation 
had significant diet effects. LF piglets had higher secretion of IL-12 than SR piglets, but FF 
piglets did not differ between the two groups. In MLN, stimulation differences were detected in 
IL-10. MLN IL-12 cytokine production, vaccination differences were not observed, yet diet 
effects were observed. MLN T-cells from FF piglets secreted more IL-12 than those from LF or 
SR piglets under stimulation. The outcomes of this study have established the dietary impact of 
formula supplemented with bLf and its effect on T-cell subpopulations, cell-mediated immune 
responses and subsequent cytokine production. Also, these data demonstrated that differences 
exists between SR piglets in comparison to LF and FF piglets and provide a framework for future 
dietary supplementation studies to heighten the infant‟s capacity to elicit a proper immune 
response. 
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 Introduction 
During infancy, rapid development is occurring and the infant is dependent on their 
immune system for protection against foreign environmental stimuli. Early nutrition, such as 
human colostrum, includes numerous immune-competent cells and soluble proteins that are 
valuable to the infant, and contribute to immune development (Calder et al., 2006). Research has 
revealed that breastfeeding stimulates variations in T-cell phenotypes, including greater 
percentages of CD8+ T-cells, lower percentages of CD4+ T-cells and more natural killer (NK) 
cells in comparison to formula-fed infants (Hawkes et al., 1999). Although no differences were 
observed in cytotoxic T-cell, helper T-cell, and memory T-cell subpopoulations, the findings 
suggest that breastfed infants have greater maturity in the development of their immune system.  
Further compromising immune protection, cell-mediated immunity against harmful pathogens is 
not effective during infancy (Fadel and Sarzotti, 2000). The TH2 bias during fetal development 
also compromises TH1 responses in newborns. Research has shown that neonates are deficient in 
TH1 associated cytokines, such as IL-12 and IFN-γ, produced by CD4+ T-cells and 
macrophages, respectively (Marodi, 2006). This immaturity of an infant is also consistent with 
underdeveloped lymph nodes and Peyers patches, and low quantities of peripheral T-cells seen in 
newborn piglets (Šinkora et al., 2009). Also, piglets are an excellent model for an immature 
immune system at birth due to lack of external antigens and passive immunity during fetal 
development, thereby decreasing levels of memory T-cells and mature B-cells at birth (Šinkora 
et al., 1998). For infants that are not breastfed, ongoing research is necessary to identify 
compounds found in breastmilk but absent in formula, to provide the most advantageous 
nutritional components to ensure optimal development of the neonate. Thus, we explored the 
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effects of a bioactive component found in breast milk, Lf, on the innate immune system of 
neonatal piglets as a model for human infants.  
In addition to Lf positive effects against harmful pathogens, Lf has been shown to be a 
mediator between innate and adaptive immunity (Seganti et al., 2004; Superti et al., 1997). The 
innate immune system is the first line of defense to environmental stimuli and is mediated by 
pattern recognition receptors, such as especially Toll-like receptors (TLR). Lipopolysaccharide 
(LPS), a cell wall component of Gram-negative bacteria commonly induces septic like 
inflammation by binding of TLR-4, although the LPS-binding domain found on Lf reduces the 
release of pro-inflammatory mediators (Yajima et al., 2005). The existence of receptors enables 
numerous activities of Lf, such as Lf‟s ability to stimulate the innate immune system thereby 
improving the infant‟s ability to fight infection (Suzuki et al., 2005). 
Research has shown that orally supplemented piglets fed Lf had an increased percentage 
of lymphocytes, a decreased amount of B lymphocytes but a higher number of T-cells (Lee et al., 
2010). When encountered with infectious pathogens, Lf has been shown to decrease rotavirus 
attachment in vitro (Superti et al., 1997). Under LPS stimulation ex vivo, Lf enhanced cytokines 
IL-12:IL-10 ratio from murine leukocytes (Hwang et al., 2006). The addition of bLf to BCG, the 
tuberculosis vaccine, infected macrophages also increased the IL-12:IL-10 ratio in vitro (Hwang 
et al., 2009b). Thus, Lf has been shown to promote TH1 mediated response.  
Limited research has been done to explore oral supplemented Lf‟s on T-cell 
subpopulations and cellular T-cell responses after stimulation. Thus, this research examines the 
effects of dietary Lf on the T-cell development during vaccination in the neonatal piglet.  
Characteristics analyzed include T-cell subpopulations, T-cell responses and cytokine responses 
after ex vivo stimulation.  
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 Materials and Methods  
Isolation of Peripheral Blood Mononuclear Cells 
 Peripheral blood was drawn into heparin-containing vacuum tubes and layered onto 
Ficoll-Paque Plus (GE Healthcare, Piscataway, NJ). PBMCs were collected from the gradient 
interface and washed three times. The isolated cells were washed three times in wash buffer after 
lysing the red blood cells. Cells were counted using a Countess automated cell counter 
(Invitrogen, Carlsbad, CA). The number of viable cells was assessed by counting after staining 
with trypan blue (Gibco Invitrogen, Grand Island, NY).   
 
Isolation of Mononuclear Cells from Tissues 
Spleen and MLN samples were collected by cutting tissues into pieces followed by 
dissociation using a Gentle MACS Dissociator (Miltenyi Biotec, Auburn, CA). The chopped 
tissue solutions were strained through a 100μm (BD Falcon, San Jose, CA) followed by a 40μm 
cell strainer (BD Falcon, San Jose, CA) to form single cell suspensions. The isolated cells were 
washed three times in wash buffer after lysing the red blood cells. Cells were counted using a 
Countess automated cell counter (Invitrogen). The number of viable cells was assessed by 
counting after staining with trypan blue (Gibco Invitrogen).   
 
Fluzone™ Preparation for Ex Vivo Analyses 
 Prior to use in ex vivo assays, Fluzone™ was dialyzed to remove additives that inhibit cell 
proliferation. Fluzone™ was placed into Spectra/Por® dialysis membrane (Spectrum 
Laboratories, Rancho Dominguez, CA) and submerged into PBS for 24h at 4°C. A Bradford 
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Assay (Bio-Rad Quick Start Bradford, Bio-Rad, Hercules, CA) was performed to establish the 
final protein concentration of Fluzone™, which was 18μg protein/mL.  
 
Assessment of T-cell subpopulations 
 A total of 1 x 10
7 
mononuclear cells per well from PBMC, spleen and MLN were plated 
in 96-well plates in a final volume of 200μL culture medium. Cells immediately underwent 
centrifugation and pellets were collected and resuspended in PBS/1% BSA/0.1% sodium azide 
until stained.   
 
Assessment of Cell-Mediated Response 
 A total of 200,000 mononuclear cells per well from PBMC, spleen and MLN were plated 
in 96-well plates in a final volume of 200 μL culture medium for 48 or 72h at 37 °C under 5% 
CO2. Cultures were stimulated at 0h with PHA (2.5μg/mL), Fluzone (10μg/mL), PMA + A23187 
(125ng/mL and 1.25μg/mL respectively) or LPS (2μg/ml). After centrifugation, supernatants 
were collected from the 72h time point. Cultures from the 48 hr time point were suspended in 
PBS/1% BSA/0.1% sodium azide until stained. Ex vivo stimulations contain only piglets from 
the December replicate. 
 
Phenotypic Identification of Mononuclear Cells from PBMC’s and Tissues for T-cells 
 The phenotypes of T lymphocytes subpopulations from PBMC, spleen and MLN were 
collected immediately after euthanasia and after ex vivo stimulation. Cell populations were 
determined by flow cytometry using a panel of fluorescently labeled mAbs. T lymphocytes were 
identified by a mouse anti-pig CD3:PE-Cy5 (Clone, Southern Biotec, Birmingham, AL). To 
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further differentiate T-cell populations, cells were stained with mouse anti-pig CD4:FITC 
(Clone, Southern Biotec) and mouse anti-pig CD8:PE (Clone, Southern Biotech).  Staining 
procedures took place on ice and samples were removed from light when possible. In brief, each 
well were blocked with 5% mouse serum (Southern Biotec) and 200μg/mL purified mouse IgG 
(Invitrogen) for 5 min each. After centrifugation, CD3 was added to the wells and incubated for 
20 min (50μL: CD3:PE-Cy5) and centrifuged again. CD4:FITC and CD8:PE were added (10μL 
each) and incubated for an additional 15 min until centrifuged. Cells were washed with PBS/1% 
BSA/0.1% sodium azide and then fixed with 2% paraformaldehyde.  Cells were assessed using a 
LSRII flow cytometer (BD™, Biosciences, San Jose, CA).The percentage of T-cell 
subpopulations was determined using FlowJo 7.9 software (FlowJo, Ashland, OR) (Table 4.1).  
CD3+ events were considered T-cells. CD3+CD4+CD8- events were considered T-helper cells. 
CD3+CD4-CD8+ were considered cytotoxic T-cells. CD3+CD4+CD8+ were considered 
memory T-cells.  
 
Cytokine Production from Ex Vivo Stimulation 
 An enzyme-linked immunosorbent assay (ELISA) was used to detect porcine IL-4, IL-6, 
IL-10, and IL-12/IL-23p40 from supernatants collected after 24h and 72h from the ex vivo 
stimulation. DuoSet‟s of each ELISA were purchased from R&D Systems (Minneapolis, MN) 
and all concentrations of antibodies used were suggested by manufacturer. Flat bottomed plates 
(Nunc, Rochester, NY) were coated with 100μL coating antibody in coating buffer PBS [7.2 pH] 
and incubated overnight at 4°C. After incubation, the plates were washed three times with 
PBS/0.05% Tween 20. Then, 300μL of 1%BSA/PBS was added to each well to block non-
specific binding for 2 h at RT. Following incubation, the plates were washed as before and 
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100μL of diluted supernatants and cytokine standard (provided by manufacturer) were added to 
each well and incubated for 2h at RT. Once the incubation passed, the plates were washed three 
times with PBS/Tween and 100μL detection antibody was added. After washing as before, 
100μL of Streptavidin-HRP diluted in 1%BSA/PBS was added to each well for 20 min at RT and 
covered from light. After washing as described above, 100μl of TMB (BD Biosciences) was 
added and allowed to develop at RT. After 20 min, the reaction was stopped with 1M sulfuric 
acid. The plate was then analyzed on a microplate spectrophotometer (SpectraMax M2
e
, 
Molecular Devices, Sunnyvale, CA) at 450nm and 570nm for correction. Concentrations of 
cytokines were calculated from the linear portion of the standard curve in pg/mL.  
 
Statistical Analysis 
 Analyses were completed using PROC GLM (general linear model) procedure within 
SAS (Version 9.2, SAS Institute, Cary, NC). The initial model was replicate, diet and 
vaccination; however, the replicate was not significant and removed from the model.  Diet 
included three groups: formula-fed (FF), lactoferrin-fed (LF) and sow-reared (SR) piglets. The 
model included vaccination, diet, and vaccination-diet interaction. If the vaccination was not 
significant, vaccinated and non-vaccinated were combined.  If Lf was not significant, LF and FF 
piglets were combined. Daily weight gain was analyzed by Chi-squared test using the PROC 
MIXED procedure within SAS. Statistical significance was defined as p<0.05, with trends 
reported as p<0.10. All data are expressed as means ± SD.  
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Results 
T Lymphocyte Populations 
 T-cell phenotype was analyzed by flow cytometry in PBMC, spleen and MLN T-cell 
populations.  Representative images of lymphocytes gating is shown in Figure 4.1. In PBMC, 
cytotoxic T-cells (CD3+CD4-CD8+) and T-helper cells (CD3+CD4+CD8-) did not differ 
between dietary treatments, or vaccination (Figure 4.2). Given that vaccination did not have an 
effect on memory T-cells (CD3+CD4+CD8+), when NV and V were pooled, FF piglets did have 
a significantly greater percentage of memory T-cells than LF piglets (p<0.0388) (Figure 4.3). 
However, the percentage of memory T-cell in SR piglets was not significantly different from the 
two diet groups. Neither MLN (Figure 4.4) nor spleen (Figure 4.5) T-cell profiles were affected 
by diet or vaccination. 
 
Cell-Mediated Immune Response 
 To determine cell-mediated immune responses, PBMC T-cell subpopulation differences 
were determined 48h after ex vivo stimulation at 37°C at 5% CO2. CD8+ T-cell differences were 
seen between diet groups. FF piglets had higher amounts of CD8+ T-cells than LF or SR 
(p<0.0001). Average %CD8+ T-cells grouped by diet were: FF (8.96±2.81), LF (7.08±2.42) and 
SR (6.14±2.77). In addition, vaccinated piglets (7.67±2.78%) exhibited a trend towards increased 
percentage of CD8+ T-cells than NV piglets (6.82±2.72%) when all stimulations were combined 
(p=0.0529). Between stimulations, differences were only seen between PMA and unstimulated, 
PHA, Fluzone™ and LPS stimulations (p<0.0001). A trend was also observed for an interaction 
between vaccination and diet (p=0.0681). Specifically, FF-V was significantly different than LF-
V, LF-NV, SR-NV and SR-V, andFF-NV was intermediate (Figure 4.6).  
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 T-helper (CD4+) PBMC differences were also seen after ex vivo stimulation; however, 
vaccination did not have an impact on these changes. Significant differences were seen between 
each diet group after stimulation (p<0.0001): FF (49.30±15.84), LF (56.03±13.33) and SR 
(62.38±10.85). PMA was again significantly dissimilar from the following stimulations: 
unstimulated, PHA, Fluzone™ and LPS (p<0.0001). Additionally, an interaction was seen 
between vaccination and diet (p=0.0320). SR-V was significantly different LF-V, FF-NV and 
FF-NV; and SR-NV and LF-NV were intermediate (Figure 4.7).  
 Alterations in PBMC memory T-cells (CD3+CD4+CD8+) were also seen after ex vivo 
stimulation. Although vaccination had no effect on memory T-cell changes, memory T-cell 
populations were affected by diet (p=0.0400). LF piglets had decreased memory T-cells 
(7.83±4.40%) in comparison to FF (9.38±6.50%) and SR (9.21±5.39%) (Figure 4.8). Memory 
T-cell changes were also observed between stimulations, with PMA being significantly different 
from unstimulated, PHA, Fluzone™ and LPS (p<0.0001). 
 A cell-mediated response was seen from lymphocytes in the spleen. CD8+ T-cell 
populations were unaffected by vaccination, but differences were seen in diet groups. SR piglets 
(12.40±6.44%) had significantly greater amount of CD8+ T-cells in spleen (p=0.0054) than LF 
or FF piglets (9.93±4.65 and 9.77±4.48%, respectively) (Figure 4.9). Stimulation differences 
were seen between PMA and unstimulated, PHA, Fluzone™ and LPS (p<0.0001).  A shift in T-
helper cell population was also observed in the spleen by dietary treatments, although 
vaccination had no effect. FF piglets had a greater percentage of CD4+ T-cells (71.24±7.81) than 
SR piglets (59.40±14.27) but LF piglets did not differ between the two (65.61±13.88). PMA was 
again significantly dissimilar from the following stimulations: unstimulated, PHA, Fluzone™ 
and LPS (p<0.0001) (Figure 4.10). Additionally, memory T-cell differences were seen between 
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diet groups. SR piglets had higher amounts of memory T-cells than LF or FF (p=0.0004). 
Average percent memory T-cells grouped by diet are: FF (7.50±1.52), LF (6.52±1.77) and SR 
(10.48±7.21). Between stimulations, differences were seen only between PMA from 
unstimulated, PHA, Fluzone™ and LPS stimulations (p<0.0001). An interaction involving 
vaccination and diet (p=0.0681) was also observed. FF-V was statistically different from SR-NV 
and SR-V, while LF-V and LF-NV where intermediates (Figure 4.11). 
 MLN CD8+ T-cell differences were seen after ex vivo stimulation in vaccination and 
stimulation. While diet had no effect, vaccinated piglets (6.94±3.10%) had higher cytotoxic T-
cells when stimulated than non-vaccinated piglets (5.98±3.13) (p=0.0293).  Stimulation with 
PMA was also significantly different from unstimulated, PHA and LPS (p<0.0001). An 
interaction between vaccination and diet was also seen (p=0.0480). FF-V was statistically 
different from FF-NV, while groups SR-NV, SR-V, LF-NV and LF-V are intermediates (Figure 
4.12). However, no significant differences were seen in MLN T-helper cells (Figure 4.13) or 
memory T-cells (Figure 4.14) due to stimulation (Model: p=0.2275, p=0.8275 respectively). 
 
Cytokine Production from Cell-Mediated Immune Response 
To further investigate cell-mediated immune responses, cytokines IL-4, IL-10, IL-12 and 
IL-6 were analyzed after ex vivo stimulation in spleen and MLN tissues.  Cytokines not included 
were below detectable limits, and therefore not added to the model. After stimulation, IL-4 was 
below detectable limits from spleen and MLN tissues. In addition, cytokine levels after 24hr 
stimulation were undetectable, therefore only 72h is reported. For spleen IL-10 cytokine 
production, vaccination and diet differences were not observed; however, differences were 
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detected between PHA and PMA stimulations (p<0.0001) (Figure 4.15).  Although vaccination 
and diet differences were not observed, IL-12 cytokine production from spleen supernatants was 
significantly different among stimulations PHA, PMA and LPS (p<0.0001). Additionally, an 
interaction between diet and vaccination was observed (p=0.0370).  SR-NV were statistically 
different from FF-NV, while groups SR-V, LF-NV, LF-V, FF-V are intermediates (Figure 4.16). 
Separately, IL-12 cytokine production after Fluzone™ stimulation had significant diet effects, if 
vaccination was removed (p=0.0394) (Figure 4.17). LF animals had higher secretion of IL-12 
than SR piglets, but FF piglets did not differ from either.  IL-6 production in spleen was detected 
after Fluzone™ and LPS stimulations, however no differences were seen (p=0.0632) (Figure 
4.18).  
MLN supernatants also saw cytokine differences between groups. Although vaccination 
and diet differences were not observed, IL-10 cytokine production from MLN supernatants were 
significantly different between PHA and PMA stimulation (p<0.006) (Figure 4.19).  MLN IL-10 
was below detectable limits in unstimulated, Fluzone™ and LPS stimulations. For MLN IL-12 
cytokine production, vaccination differences were not observed, yet diet effects were detected 
(p=0.0041) (Figure 4.20). Importantly, IL-12 was detected from unstimulated cells, but not from 
Fluzone™ or LPS, yet significance was seen by stimulation (p<0.0001). FF piglets were 
statistically different that SR piglets, while LF was an intermediate (p=0.0041). No differences 
were observed from MLN IL-6 cytokine production (p=0.9802) when stimulated with PMA.  
MLN IL-6 was also below detection for unstimulated, PHA, Fluzone™ and LPS samples 
(Figure 4.21).    
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Figure 4.1. Example of flow cytometry T-lymphocyte separation and gating. T 
lymphocytes were identified by a mouse anti-pig CD3:PE-Cy5 and mouse anti-pig 
CD4:FITC and mouse anti-pig CD8:PE to further differentiate T-helper and cytotoxic T-
cells, respectively. In the forward side scatter (FSC) and side scatter (SSC), the lymphocytes 
were gated and selected (panel a). Then, the CD3+ T-cells were selected (panel b). After 
selecting within this population, a graph was generated for the CD4+ and CD8+ T-cells 
(panel c) using anti-CD4 and anti-CD8. Based on single stains, the gating was set and 
percentages of these populations are obtained. CD8+ T-cells are shown in the upper left 
quadrant, CD4+ T-cells are shown in the lower right quadrant, and double positive memory 
T-cells are shown in the upper right quadrant.  
 
a) b) c) 
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Figure 4.2. Average PBMC T-cell populations.  No statistical differences were seen 
between vaccination and diet groups in CD4+, CD8+ and CD4+CD8+ T-cells. Data are 
expressed as means±SD. 
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Figure 4.3. PBMC Memory T-cell Populations. T-cell populations are expressed as a 
percent of CD3+ events. The memory T-cell population in PBMC was affected by diet, 
when vaccination was removed from the model (p=0.0388).  FF piglets had significantly 
higher memory T-cells than LF piglets, but SR piglets did not differ between the two. 
Data are expressed as means±SD. Different letter superscripts indicate statistical 
differences.  
A 
AB 
B 
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Figure 4.4. Average T-cell Populations in MLN.  T-cell populations are expressed as a 
percent of CD3+ events. No significant differences were seen between vaccination or diet 
groups in CD4+, CD8+ and CD4+CD8+ T-cells. Data are expressed as means±SD. 
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Figure 4.5. T-cell Populations in Spleen.  No significant differences were seen 
between vaccination or diet groups in CD4+, CD8+ and CD4+CD8+ T-cells. Data are 
expressed as means±SD. 
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Figure 4.6. PBMC CD8+ T-Cell Populations following 48hr Stimulation.  T-cell 
populatations are expressed as a percent of CD3+ events.  FF piglets had significantly 
greater CD8+ T-cells after stimulation than LF or SR piglets (p<0.0001).  In addition, PMA 
was statistically different from all other treatments (p<0.0001). Data are expressed as 
means±SD. Different letter superscripts indicate statistical differences. 
Model: p<0.0001 
Vaccination: p=0.0529 
Diet: p<0.0001 
Stimulation: p<0.0001 
Diet*Vaccination: p=0.0681 A A 
A 
A 
A 
B B 
B 
B 
B 
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Figure 4.7.  PBMC CD4+ T-Cell Populations following 48hr Stimulation. T-helper cell 
differences were seen due to diet and stimulation after ex vivo stimulation. T-cell populations 
are expressed as a percent of CD3+ events. Denoted by letters, FF piglets had the least 
percentage of CD4+ T-cell compared to LF and then SR piglets (p<0.0001). PMA was 
statistically different than all stimulations (p=0.0002). An interaction between diet and 
vaccination (p=0.0320) are denoted by LSM: SR-V is A, SR-NV and LF-NV are denoted 
AB, and LF-V, FF-NV and FF-NV are denoted B. Data are expressed as means±SD. 
Different letter superscripts indicate statistical differences. 
Model: p=0.0015 
Vaccination: p=0.8819 
Diet: p<0.0001 
Stimulation: p=0.0002 
Diet*Vaccination: p=0.0320 
A A A 
A 
B B B 
A 
B 
B C 
C 
C C 
C 
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Figure 4.8. PBMC Memory T-Cell Populations following 48hr Stimulation. PBMC 
memory T-cell differences were seen due to diet and stimulation after ex vivo stimulation. 
T-cell populations are expressed as a percent of CD3+ events. Although diet differences 
were seen (p=0.0400), LSM denoted all groups A. PMA was statistically different from all 
other stimulations (p<0.0001). Data are expressed as means±SD. 
Model: p<0.0001 
Vaccination: p=0.9741 
Diet: p=0.0400 
Stimulation: p<0.0001 
Diet*Vaccination: p=0.391 
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Figure 4.9. CD8+ T-Cell Populations in Spleen following 48hr Stimulation. Spleen 
CD8+ T-cell differences were seen due to diet and stimulation after ex vivo stimulation. T-
cell populations are expressed as a percent of CD3+ events. While vaccination had no effect, 
SR piglets had greater CD8+ T-cells than LF or FF piglets (p=0.0054). In addition, PMA 
stimulation was statistically different from unstimulated, PHA, Fluzone and LPS 
(p<0.0001). Data are expressed as means±SD. Different letter superscripts indicate statistical 
differences. 
Model: p<0.0001 
Vaccination: p=0.3407 
Diet: p=0.0054 
Stimulation: p<0.0001 
Diet*Vaccination: p=0.5363 
 
A 
A 
A 
B 
A 
B B 
B B 
A 
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Figure 4.10. CD4+ T-Cell Populations in Spleen following 48hr Stimulation. Spleen 
CD4+ T-cell differences were seen due to diet and stimulation after ex vivo stimulation.  T-
cell populations are expressed as a percent of CD3+ events. While vaccination had no effect, 
SR (A) piglets had greater CD4+ T-cells than LF(AB), even more so than FF (B) piglets 
(p=0.0006). Data are expressed as means±SD. Different letter superscripts indicate statistical 
differences. 
Model: p<0.0001 
Vaccination: p=0.1077 
Diet: p=0.0006 
Stimulation: p<0.0001 
Diet*Vaccination: p=0.2714 
 
A 
AB 
B 
A 
AB 
B 
A 
AB 
B 
A 
AB 
B B 
A AB 
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Figure 4.11. Memory T-Cell Populations in Spleen following 48hr Stimulation. Spleen 
Memory T cell differences were seen due to diet and stimulation after ex vivo stimulation.  
T-cell populations are expressed as a percent of CD3+ events. While vaccination had no 
effect, SR (A) piglets had greater memory T cells than LFand FF (B) piglets (p=0.0004). 
PMA was also significantly different (p<0.0001) from stimulations: unstimulated, PHA, 
Fluzone and LPS.  A diet and vaccination interaction was additionally seen. The interaction 
was observed in SRNV piglets (A), which were statistically different from CN, CV, LFNV, 
LFV, and SRV groups (B) (p=0.0147). Data are expressed as means±SD. Different letter 
superscripts indicate statistical differences. 
A 
B 
A 
B 
A 
B 
A 
B 
A 
B 
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Figure 4.12. CD8+ T-Cell Populations in MLN following 48hr Stimulation. MLN 
CD8+ T-cell differences were seen vaccination and stimulation after ex vivo stimulation.  
T-cell populations are expressed as a percent of CD3+ events. While diet had no effect, 
vaccinated piglets had higher cytotoxic T-cells when stimulated than non-vaccinated 
piglets (p=0.0293).   Stimulation PMA was also significantly different from unstimulated, 
PHA and LPS (p<0.0001). An interaction between vaccination and diet was additionally 
seen (p=0.0480). Data are expressed as means±SD.  
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Figure 4.13. CD4+ T-Cell Populations in MLN following 48hr Stimulation. MLN 
CD4+ T-cell differences were not observed after ex vivo stimulation (p=0.2275). T-cell 
populations are expressed as a percent of CD3+ events. Data are expressed as means±SD. 
Model: p=0.2275 
Vaccination: p=0.3500 
Diet: p=0.0025 
Stimulation: p=0.9631 
Diet*Vaccination: p=0.107 
 
 
62 
 
 
Figure 4.14. Memory T-Cell Populations in MLN following 48hr Stimulation. MLN 
memory T-cell differences were not observed after ex vivo stimulation (p=0.8275). T-cell 
populations are expressed as a percent of CD3+ events. Data are expressed as means±SD. 
Model: p=0.8275 
Vaccination: p=0.4654 
Diet: p=0.5761 
Stimulation: p=0.0554 
Diet*Vaccination: p=0.6622 
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Figure 4.15.  IL-10 Secretion by Spleen T-cells.  Although vaccination and diet 
differences were not observed, IL-10 cytokine production from spleen supernatants were 
significantly different from one another by stimulation (p<0.0001). Unstimulated and 
Fluzone™ samples were below detection. Data are expressed as means±SD. 
Model: p=0.0026 
Vaccination: p=0.2409 
Diet: p=0.7803 
Stimulation: p<0.0001 
Diet*Vaccination: p=0.9543 
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Figure 4.16. IL-12 Secretion by Spleen T-cells. Although vaccination and diet 
differences were not observed, IL-12 cytokine production from spleen supernatants were 
significantly different by stimulation (p<0.001). In addition, an interaction between diet 
and vaccination was seen (p=0.037). Data are expressed as means±SD. 
Model: p=0.0003 
Vaccination: p=0.2320 
Diet: p=0.1670 
Stimulation: p=0.0005 
Diet*Vaccination: p=0.0370 
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Figure 4.17.  IL-12 Secretion by Spleen T-cells differed by Diet. When 
vaccination was removed from the model, diet differences were observed in 
IL-12 production from spleen tissues when stimulated with Fluzone™ 
(p=0.0394). Data are expressed as means±SD. Different letter superscripts 
indicate statistical differences. 
A 
AB 
  
B 
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Figure 4.18.  IL-6 Secretion by Spleen T-cells. No statistical differences were observed 
of IL-6 production from spleen tissues after ex vivo stimulation (Model: p=0.0632). Data 
are expressed as means±SD. 
Model: p=0.0632 
Vaccination: p=0.7451 
Diet: p=0.2199 
Stimulation: p=0.0057 
Diet*Vaccination: p=0.8910 
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Figure 4.19.  IL-10 Secretion by MLN T-cells. Although vaccination and diet differences 
were not observed, IL-10 cytokine production from MLN supernatants were significantly 
different by stimulation (p=0.006).  Data are expressed as means±SD. 
Model: p=0.0412 
Vaccination: p=0.5341 
Diet: p=0.7393 
Stimulation: p=0.0006 
Diet*Vaccination: p=0.6028 
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Figure 4.20. IL-12 Secretion by MLN T-cells. Vaccination differences were not observed 
in MLN IL-12 cytokine production, yet diet differences were detected (p=0.0041).  
Importantly, IL-12 was detected from unstimulated cells, but not from Fluzone™ or LPS. 
Data are expressed as means±SD. Different letter superscripts indicate statistical differences. 
Model: p<0.0001 
Vaccination: p=0.5393 
Diet: p=0.0041 
Stimulation: p<0.0001 
Diet*Vaccination: p=0.1556 
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Figure 4.21. IL-6 Secretion by MLN T-cells. No differences were observed from 
MLN IL-6 cytokine production (Model: p=0.9802).  Unstimulated, PHA, Fluzone™ 
and LPS were below detection.   Data are expressed as means±SD. 
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Discussion 
Lactoferrin (Lf) is a glycoprotein expressed in biological fluids to transport iron in milk 
and other secretions functioning as a major component to the innate immune system (Gonzalez-
Chavez et al., 2009). It has many biological implications, including immune response function as 
an antioxidant (Mulder et al., 2008) and protection against microbial (Moshynskyy et al., 2003) 
and viral pathogens (Hung et al., 2010). In addition, Lf has been shown to exhibit anti-
inflammatory properties (Puddu et al., 2011). This study examined infant immune development 
using the neonatal piglet model to further investigate bLf on vaccination and T-cell phenotype 
responses. Overall, vaccination and serum Ig profiles in the neonatal piglets were minimally 
affected by dietary treatment of bLf.  Additionally, bLf was found to have little impact on T-cell 
phenotype or cell-mediated immune responses. bLf was also found to have no negative impacts 
on development, dietary tolerance or immune characteristics analyzed.   
One major difference between the human infant and neonatal piglet is the absence of 
immunoglobulin transfer during prenatal development in piglets, leaving their immune system 
vulnerable to infection after birth (Sangild, 2003). Therefore, piglets are dependent on colostrum 
and milk as a source of external antigens for maturation of the immune system. Limited amounts 
of stimuli have been shown to decrease memory T-cells and mature B-cells at birth in piglets 
(Šinkora et al., 2009). A difference in the piglet immune system from humans and various other 
species is the high percentage of double positive CD4+CD8+ T-cell subpopulations. This 
subpopulation, which is considered to represent memory T-cells, have been shown to rise with 
age and maturation of the immune system (Zuckermann and Gaskins, 1996). Although dietary 
treatments and vaccination had minimal impact on the percentage of memory T-cells in PBMCs, 
MLN and spleen, a dietary impact was found in PBMC when vaccination was removed. Dietary 
bLf decreased the percentage of memory T-cells in PBMC in comparison to SR and FF piglets. 
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Although no research has been examined memory T-cell populations from orally 
supplementation of Lf, vaccination has induced generation of memory T lymphocytes in swine 
(Ober et al., 1998).  
Infants are born with a TH2 bias, which must be down-regulated successfully to a TH1 
response since the TH1 associated cytokines are necessary to defend the infant effectively against 
bacterial and viral infections by aggressively attacking foreign antigens (Reinhard et al., 1998). 
The decline in neonatal TH1 responses are observed from decreased TH1 associated cytokines, 
such as IL-12 and IFN-γ, produced by CD4+ T-cells and macrophages (Marodi, 2006).  
Recently, in vivo models have shown that orally supplementation of pLf increased TH1 cytokines 
such as IFN-γ and IL-12 suggesting that Lf could increase cell-mediated immunity (Hung et al., 
2010).  Hung and researchers used concentrations 2.0% w/w pLf as a feedstuff additive, which is 
greater than used in this study. 
The ability of Lf to modulate antigen presentation to affect T-cell activity is associated 
with the cell types that have Lf receptors (Suzuki et al. 2005). For example, monocytes and 
lymphocytes, which contain Lf receptors, aid in the maintenance and generation of antigen-
specific B and T-cells. Lf has been shown to affect the contribution of lymphocytes to function 
as antigen-presenters to activate CD4+ T-cells to produce IFN-γ (Hwang et al. 2007). In 
addition, Lf has been shown to increase IBD vaccination response in chickens when orally 
supplemented (Hung et al., 2010). In this study, oral supplementation of Lf had no effect on 
vaccination response in neonatal piglets, although a trend was observed that suggests SR 
enhances antibody response (p=0.0953). The ability of breastmilk to enhance antibody responses 
has been previously demonstrated in infants (Silfverdal et al., 1999).  Although dietary Lf had no 
impact of IgM and IgG concentration in serum, it has been observed that Lf can enhance Ig 
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concentrations on mucosal surfaces (Debbabi et al., 1998). Differences in total IgM that were 
identified, in comparison to total IgG, could be due to low concentrations of IgM in serum.   
Although no dietary differences in PBMC T-cell subpopulations were observed, changes 
in T-cell populations upon ex vivo stimulation were observed.  FF piglets had decreased CD4+ T-
cells after mitogen stimulation compared to LF or SR piglets (p<0.0001). This is interesting 
because an increase in CD4+ T-cell suggests that Lf may be contributing to increase antigen 
presentation.  In addition, FF piglets exhibited greater PBMC CD8+ T-cell populations after ex 
vivo stimulation (p<0.0001) compared to LF and SR piglets, suggesting that Lf may be 
modulating the cell survival of CD8+ T-cells.  This increased PBMC CD4+ T-cell survivability 
upon stimulation could be caused by TH1 associated cytokines promoting differentiation of naïve 
CD4+ T-cells into effector CD4+ T-cells, thereby increasing protection against infectious 
pathogens (Marodi, 2006).  
Hwang and colleagues (2009a) have shown that Lf used as an adjuvant with BCG 
vaccine up-regulated CD4+ T-cells producing IFN-γ in splenocytes of animals. Again in this 
study, T-cell subpopulations of splenocytes were unaffected by dietary Lf; however, under 
mitogen stimulation ex vivo dietary differences were observed. CD4+ T-cells in splenocytes 
were greater in SR piglets versus FF piglets, but LF piglets were not statistically different from 
either group (p=0.0006). This is interesting because supplementation of bLf may be modulating 
CD4+ T-cell survival in splenocytes upon activation. In addition, CD8+ splenocytes were greater 
in SR in comparison to FF and LF piglets (p=0.0054) which is consistent with higher 
percentages of CD8+ T-cells in mononuclear cells from breastfed infants (Hawkes et al., 2010).  
Our research showed that Fluzone™ stimulation of splenocytes increased IL-12 secretion in LF 
piglets compared to SR piglets. In addition, SR piglets had greater IL-12 secretion than FF in 
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MLN under stimulation, but LF piglets were not significantly different from either dietary 
treatment. These data suggest that Lf is promoting TH1 cytokines, thereby enhancing the 
neonate‟s ability to fight infection (Marodi, 2006).  
Little vaccination effects were observed, although piglets that were vaccinated had higher 
CD8+ T-cells than piglets than were non-vaccinated in MLN after stimulation (p=0.0293). 
Intranasal immunization of mice suggests that antigen-specific proliferating T cells can be found 
is distal lymph nodes, suggesting migration of locally primed T-cells (Ciabattini et al., 2011).  
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Chapter 5 
Conclusions and Future Directions 
 This study focused on the impact of Lf, a bioactive component found in human milk, on 
vaccination response, serum IgG profiles and the T-cell phenotype response after mitogen 
stimulation. Our first objective was to assess the ability of Lf to influence antibody production in 
a neonatal model against vaccination versus FF piglets.  It is critical to investigate the differences 
in formula additives to enhance our understanding of how breastfeeding is able to attribute to 
immune development and maturation. The implication of this research can be extensive, 
especially when applied to improving the quality of the neonate‟s immune system and its 
capability to fight infectious pathogens.  Generally, our findings showed that Lf had little impact 
on vaccination response, serum Ig profiles and T-cell subpopulations, but did impact T-cell 
populations after stimulated conditions.   
 Future investigation involving Lf on vaccination response could be focused in mucosal 
immune response.  Because Lf is produced by mammary and found in mucosal secretions, it may 
have a greater impact on the response to vaccination with FluMist®, the live attenuated influenza 
vaccination (LAIV) (Lonnerdal and Iyer, 1995). It has also been shown that LAIV vaccination in 
children 6-months to 4-years of age are able to develop virus specific IFN-γ CD4+and CD8+ T-
cells, similar to the currently used trivalent influenza vaccination (TIV). In addition, more 
research could examine various infection models in order to further the understanding of whether 
Lf can impact immunological differences in antibody response and T-cell subpopulations. This 
would aid in identification the characteristics necessary to heighten the infant‟s ability to elevate 
the appropriate immune response to a vaccination.      
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Appendix A 
Supplemental Information: T-cell Population Changes after 48 hour in Culture and T-cell 
Population Summaries 
Alterations in PBMC Subpopulations after 48h Culture 
 T-cell subpopulation changes were seen after 48hr culture.  PBMC CD8+ T-cells were 
significantly different after 48 incubation (p<0.0001). Before culture, the combined T-cell 
population was 18.357±3.32 %CD8+ T-cells and after culture the CD8+ T-cells decreased to 
7.785±2.711% (Figure A.1). Opposing, CD4+ T-cells significantly decreased after 48h in 
culture (p<0.0184): T-cell population 37.25±12.68 %CD4+ T-cells and 48h culture is 
50.025±16.64 % CD4+ T-cells (Figure A.2). T-cell subpopulation changes were also seen in 
memory T-cells (CD3+CD4+CD8+. After 48h, memory T-cells significantly decreased 
(p<0.0001) from 8.638±3.319 % memory T-cells to 5.886±2.811% memory T cells (Figure 
A.3).  
 
T-Cell Populations 
 Summarization of spleen (Figure A.4) and MLN (Figure A.5) T-cell populations, no 
significance was observed.  
 
Fluzone IgG Concentration 
 Fluzone IgG concentration from August 2011 replicate only. Data is expressed as optical 
density from the 1:100 dilution from the sample. Data could not be combined with the November 
and December 2011 replicates due to sow-reared piglets response to Fluzone™ vaccination 
(Figure A.6). On d21, vaccinated piglets were greater than non-vaccinated (p<0.0001). SR 
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piglets had higher Fluzone IgG compared to FF and LF groups (p<0.0001).  Also, an interaction 
was observed between vaccination and diet (p<0.0001). LSM denoted SR-V as A, and all groups 
were denoted B. 
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Figure A.1. CD8+ PBMC T-cell Population Changes After 48hr in Culture. CD8+ T 
cells decreased more than half after 48h in culture (Model: p<0.0001). Data are expressed 
as means±SD. 
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Figure A.2. CD4+ PBMC T-cell Population Changes After 48hr in Culture. CD4+ T 
cells increased by ~13% after 48h in culture (Model: p=0.0529). Data are expressed as 
means±SD. 
86 
 
 
Figure A.3. Memory PBMC T-cell Population Changes After 48hr in Culture.  
Memory T cells decrease by ~3% after 48h in culture (Model: p=0.0017). Data are 
expressed as means±SD. 
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Figure A.4. Spleen T-cell Subpopulations after ex vivo stimulation. Data are expressed as 
means±SD. 
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Figure A.5. MLN T-cell Subpopulations after ex vivo stimulation. Data are expressed as 
means±SD. 
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Figure A.6. Circulating Fluzone™ IgG Concentration from August 2011 replicate on 
d21. On d21, vaccinated piglets were greater than non-vaccinated (p<0.0001, not shown).  
SR piglets had higher Fluzone IgG compared to FF and LF groups (p<0.0001).  Also, an 
interaction was observed between vaccination and diet (p<0.0001). Data are expressed as 
means±SD. 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
A 
Model: p<0.0001 
Diet: p<0.0001 
Vaccination: p<0.0001 
Diet*Interactions: p<0.0001 
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Appendix B 
Supplemental Information: Incubation of T-cells with Fluzone™ Peptides has no Effect on 
T-cell Ratio 
Fluzone Peptide T-cell Stimulation 
 In March 2011, a pilot was conducted to stimulate PBMC from piglets vaccinated with 
Fluzone™ on d7 and d14 then euthanized on d21 as previously performed.  After isolation of the 
PBMC, 1 x 10
6
 cells/ml were plated.  Only vaccinated piglets were analyzed for this pilot. 
Samples were unstimulated, or stimulated with: Fluzone™ (Sanofi Pasteur, Swiftwater, PA) at 
concentrations 1μg/ml, 5μg/ml or 10μg/ml. PBMC from vaccinated piglets were additionally stimulated 
with peptides: ProMix Influenza A NP Protein, ProMix Influenza A HA Brisbane, ProMix Influenza A 
MP2 Protein (thinkpeptides, Oxford, UK) at concentrations 1μg/ml, 5μg/ml, 10μg/ml, 50μg/ml and 
100μg/ml. In same concentrations, the individual peptides were mixed equally and used to stimulate the 
cells.    In comparison to unstimulated PBMC, Fluzone™ stimulation showed a marked increase 
in CD4+:CD8+ T-cell ratio in concentrations 5μg/ml and 10μg/ml. Thus, our methods in Chapter 
4 stimulated cells from PBMC and spleen with Fluzone™ at 10μg/ml. Although, no differences 
were observed when cells were stimulated with individual peptides or mixed together.  
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Figure B.1. Ratio of CD4+:CD8+ T-cells After Fluzone™  Peptide Stimulation. 48hr Fluzone 
peptide stimulation had no impact on CD4+:CD8+ ratio (Model: p<0.7804).   
